US3691271A - Sanitary napkin having homogeneously distributed microcapsules filled with delay releasable bactericidal and fungicidal deodorant - Google Patents

Sanitary napkin having homogeneously distributed microcapsules filled with delay releasable bactericidal and fungicidal deodorant Download PDF

Info

Publication number
US3691271A
US3691271A US8721A US3691271DA US3691271A US 3691271 A US3691271 A US 3691271A US 8721 A US8721 A US 8721A US 3691271D A US3691271D A US 3691271DA US 3691271 A US3691271 A US 3691271A
Authority
US
United States
Prior art keywords
deodorant
microcapsules
sanitary napkin
homogeneously distributed
fungicidal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US8721A
Other languages
English (en)
Inventor
Roger Charle
Charles Zviak
Gregoire Kalopissis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US3691271A publication Critical patent/US3691271A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/408—Virucides, spermicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer
    • Y10T428/2987—Addition polymer from unsaturated monomers only

Definitions

  • microcapsules are homogeneously dis- 128/2'70 284 tributed in the cellulose batting or in alternating layers on the fabric to effect a delayed release of the References Cited deodorant therefrom, the walls of said microcapsules being permeable or soluble on contact with the fluid associated with menstrual discharge.
  • the present invention relates to a treating cosmetic composition, preferably a deodorant composition, in which the deodorant effect is delayed with reference to the moment of application of the composition, the effect appearing only after perspiration.
  • Deodorant compositions used for the care of the body whose deodorant effect is immediate after application are already known, but it is obvious that such compositions cannot give entire satisfaction. In the case in which the composition is used preventatively, the deodorant effect is exerted as soon as it is applied with gradually diminishing effectiveness. Moreover, and on the other hand, application of such a composition at the desired moment also presents obvious difficulties. It must be added that there is the necessity of using the active product in excess at the time of .application of the composition, or else there must be numerous applications with all the bother that this entails.
  • the present invention is intended to obviate the above mentioned difficulties, and especially to avoid occurrence of the deodorant effect from the moment of application of the deodorant cosmetic composition.
  • the present invention thus relates to a new deodorant composition containing the active elements of an ordinary deodorant composition, the said elements only acting at the time of perspiration or after a certain lapse of time after sufficient perspiration.
  • the present invention also relates to the process of deferred release effected in situ after perspiration, at the location of application of the cosmetic composition.
  • Thepresent invention also relates to the process of preparation of the above mentioned cosmetic deodorant compositions.
  • the support phase of the deodorant composition is constituted by the usual vehicle of these compositions, the said support phase being cellulose batting or any absorbent fabric on which the treating phase is deposited.
  • the treating phase which is constituted by microencapsulated compounds or agents contained in the above mentioned vehicle causes the perspiration odors or other odors to disappear at the end of a certain period after occurrence of the said odors.
  • a modification of the release process consists in attaining or accelerating the destruction of envelope E by a mixture of water and another suitable agent.
  • capsules C contain in addition to the deodorant composition, e.g., a lower alcohol such as ethanol or a polysaccharide, envelope E being sufficiently permeable to the water of perspiration.
  • a copolymer of styrene and completely hydrolyzed maleic acid for example, the water of perspiration penetrates through envelope E of the capsule in which it constitutes a mixture, e.g., water-ethanol which for a content of about 50:50 readily dissolves the said envelope B.
  • a larger or smaller number of capsules release the deodorant product, in a way that is accelerated by the fact that more and more rapidly the optimal proportions for the solvent mixture are reached.
  • Envelope E of microcapsules C which contain the deodorant compositions are constituted by multifarious compounds, on condition that they be sufficiently dissolved or permeable in contact with the perspiration water, taking into account the pH thereof, or on condition that they be destroyed by microorganisms also developing in the course of perspiration.
  • the compounds forming envelopes E are selected especially from the following: gelatin, ethyl cellulose, cellulose acetophthalates, treated or untreated polyvinyl alcohols.
  • microcapsules are used whose sizes range from 30 to 500 microns, preferably from to 250 microns, and the weight of envelopes E with reference to the total weight of capsules C ranges from 1 to 10 percent, preferably 3 to 6 percent by weight.
  • a powder, a stick or a lotion can be used as vehicle for capsules C, the lotion advantageously being used as an aerosol.
  • Capsules C contain for example deodorant agents such as compositions known as G4 i.e., 2,2'-dihydroxy- 5,5'dichloro-diphenyl methane G11, i.e., 2,2- methylenebis (3,4,6-trichlorophenal), quaternary ammonium compositions, alums, anilide derivatives such as salicylanilides and chlorophenyl hexanes, or ordinary deodorant cosmetic compositions.
  • G4 i.e., 2,2'-dihydroxy- 5,5'dichloro-diphenyl methane G11, i.e., 2,2- methylenebis (3,4,6-trichlorophenal)
  • quaternary ammonium compositions quaternary ammonium compositions
  • alums anilide derivatives such as salicy
  • microorganisms capable of destroying the microorganisms which occur in perspiration and which to a great extent are responsible for the odors that are to be suppressed.
  • microcapsules C are used in an appropriate range insofar as size and envelope thickness are concerned.
  • the density of the mixture can be adjusted to that of the microcapsules by addition of an excess of one of the ingredients or by introduction of a suitable inert substance (inert with reference to the other components).
  • capsules C are introduced either directly at any moment of the preparation, or in pre-mixtures obtained from components of the vehicle of the cosmetic composition. It is likewise very useful to add a moistener to the capsules before introducing them into the deodorant composition or into a pre-mixture.
  • the deodorant compound of the invention is presented as a powder, a stick, a lotion or a sanitary napkin.
  • the cosmetic composition has in addition to capsules C, ingredients in the form of solid particles such as talcum powder and similar powders.
  • ingredients in the form of solid particles such as talcum powder and similar powders.
  • the microcapsules C not be destroyed by mechanical pressure during manufacture and for this purpose pre-mixtures are advantageously used, the envelopes being thicker and capsules C being smaller.
  • envelope E of the microcapsules is a compound that is sufficiently elastic so that the capsules C are not destroyed in spraying by rapid increase in volume due to sudden decompression.
  • the present invention relates especially to deodorant cosmetic compositions, but it is obvious that it also applies very generally to all compositions for treatment that are used for body care in which perspiration plays a significant role either directly or indirectly.
  • microcapsules C whose envelope E is coated on the outside at least by a thin envelope here designated E, said thin envelope being inert with reference to the vehicle of the cosmetic composition and having a degree of elasticity which is greater than that of envelopes E, the said envelopes being water-permeable and subject to destruction by an acid or by a waterethanol mixture.
  • envelopes E allows use of envelopes E which have the above mentioned properties but for which it is not necessary that the compounds comprising them be inert to the vehicle of the cosmetic composition.
  • the association of envelopes E and E allows therefore the attaining more readily of microcapsules of the invention especially in the case in which the cosmetic composition is stored as aerosol since the microcapsules must not be destroyed at the moment of projection.
  • the envelopes E may be prepared with the polymers and colloids already mentioned.
  • a vehicle (perfumed powder) is prepared with the following mixture:
  • talc 98 perfume 2 There is also prepared, by grinding, a mixture of:
  • a perfumed alcohol solution is prepared using:
  • microencapsulated in polyvinyl alcohol the size of the microcapsules being from 30 to 50 microns.
  • This lotion is used with a sprayer which must be agitated just before use.
  • the microcapsules are deposited on the skin at the selected places, and the perspiration dissolves their jacket when it forms, releasing the active products and thus suppressing any troublesome odor.
  • Aerosol deodorant lotion Hexachlorophene is microencapsulated, using polyvinyl acetate or ethyl cellulose, the size of the microcapsules being 30 microns on the average.
  • a perfumed alcohol is then prepared with:
  • Example 3 To prepare a deodorant solution there is added 5 percent by weight microcapsules to the original mixture, and this is stored as aerosol as in Example 3, the can to be agitated just before use.
  • the anhydrous deodorant composition is deposited on the skin at the selected places: the microcapsule envelopes dissolve with appearance of sweat, thus effectin g the desired deodorizing action.
  • microencapsulated in an acetophthalate cellulose polymer there is incorporated in it 0.5 percent hexachlorophene microencapsulated in an acetophthalate cellulose polymer, the size of the microcapsules being of the order of to 50 microns.
  • microcapsules are uniformly distributed in the pasty mass which is extruded, cooled and cut into sticks which are then packaged.
  • the delayed deodorant action is obtained in the same conditions as in the preceding examples.
  • EXAMPLE 6 Deodorant sanitary napkin The following solution is microencapsulated: isopropyl myristate 60 Microencapsulation is effected with polyvinyl acetate, the size of the microcapsules being on an average 30 to 50 microns.
  • microcapsules are homogeneously distributed in the body of a napkin made of cellulose batting or else they are distributed in alternating layers on a fabric of pa er or cotton.
  • a sanitary napkin consisting essentially of a body of an absorbent material of cellulose batting or layered paper or cotton fabric and a multiplicity of individual microcapsules enveloping effective amounts of a bactericidal and fungicidal deodorant agent, said microcapsules being homogeneously distributed in said cellulose batting or in alternating layers on said paper or cotton fabric, the size of each of said microcapsules ranging from 30-500 microns, the walls of said microcapsules being permeable or soluble on contact with the fluid associated with menstrual discharge whereby the release of said deodorant agent from said microcapsules in said sanitary napkin is delayed until contact with sufficient amounts of said fluid to permeate or solubilize the walls of said homogeneously distributed microcapsules, said walls of said microcapsules being made from a material selected from the group consisting of gelatin, ethyl cellulose, cellulose acetophthalate, polyvinyl alcohol and polyvinyl acetate and the density of
  • microcapsules have a size ranging from 30 50 microns. 5O

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Materials Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
US8721A 1969-02-04 1970-02-04 Sanitary napkin having homogeneously distributed microcapsules filled with delay releasable bactericidal and fungicidal deodorant Expired - Lifetime US3691271A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU57907 1969-02-04

Publications (1)

Publication Number Publication Date
US3691271A true US3691271A (en) 1972-09-12

Family

ID=19725912

Family Applications (1)

Application Number Title Priority Date Filing Date
US8721A Expired - Lifetime US3691271A (en) 1969-02-04 1970-02-04 Sanitary napkin having homogeneously distributed microcapsules filled with delay releasable bactericidal and fungicidal deodorant

Country Status (9)

Country Link
US (1) US3691271A (xx)
BE (1) BE745456A (xx)
CA (1) CA952025A (xx)
CH (1) CH516309A (xx)
DE (1) DE2004872A1 (xx)
FR (1) FR2033294B1 (xx)
GB (1) GB1285244A (xx)
IT (1) IT1011504B (xx)
LU (1) LU57907A1 (xx)

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856014A (en) * 1972-10-23 1974-12-24 Jex Co Ltd Sanitary napkin with porous resin powder deodorant
US3875942A (en) * 1972-11-29 1975-04-08 Colgate Palmolive Co Diaper containing powder having properties beneficial to skin
US3903232A (en) * 1973-10-09 1975-09-02 Grace W R & Co Dental and biomedical foams and method
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US3939838A (en) * 1974-08-20 1976-02-24 Unicharm Kabushiki Kaisha Article for treating menstrual fluid
US4078051A (en) * 1973-02-05 1978-03-07 L'oreal Cross-linked starch coated antiperspirant derivative of aluminum, process for its preparation and antiperspirant composition containing same
US4080439A (en) * 1973-02-05 1978-03-21 L'oreal Starch coated antiperspirant derivative of aluminum, process for its preparation and antiperspirant composition containing the same
US4080438A (en) * 1973-02-05 1978-03-21 L'oreal Starch coated antiperspirant derivative of aluminum, process for its preparation and antiperspirant composition containing the same
US4147766A (en) * 1976-06-09 1979-04-03 Armour Pharmaceutical Company Macrospherical particles of anti-perspirants
DE2901068A1 (de) * 1978-01-13 1979-07-19 Unilever Nv Desodorierender, poroeser gebrauchsgegenstand zur beruehrung mit menschlicher haut oder haar, verfahren zu seiner herstellung und seine verwendung
WO1980000008A1 (en) * 1978-06-09 1980-01-10 Donald Enterprises Inc Contraceptive-antivenereal disease tampon
US4183911A (en) * 1973-09-18 1980-01-15 Colgate-Palmolive Company Antiperspirant compositions
US4186743A (en) * 1978-02-28 1980-02-05 Personal Products Company Perfuming self-adhering napkins
US4237591A (en) * 1977-05-23 1980-12-09 Personal Products Company Deodorant mini-pad sanitary napkin
US4309997A (en) * 1978-06-09 1982-01-12 Donald Jack W Contraceptive and/or antivenereal disease tampon
US4363322A (en) * 1978-04-13 1982-12-14 Andersson A E Bror Deodorizing and disinfecting liquid-absorbing product and process for production thereof
US4369173A (en) * 1974-11-27 1983-01-18 Wickhen Products, Inc. Antiperspirant compositions
US4528125A (en) * 1983-03-03 1985-07-09 The Dow Chemical Company Sustained release compositions
US4582717A (en) * 1982-02-06 1986-04-15 Bayer Aktiengesellschaft Process for production of vaginal tampons containing pharmaceutical active compound
US4583980A (en) * 1980-08-16 1986-04-22 Henkel Kommanditgesellschaft Auf Aktien Sanitary hygiene products having odor-preventing properties
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
US4732763A (en) * 1978-10-17 1988-03-22 Stolle Research And Development Corporation Active/passive immunization of the internal female reproductive organs
USRE32713E (en) * 1980-03-17 1988-07-12 Capsule impregnated fabric
US4818522A (en) * 1987-09-14 1989-04-04 Reheis, Inc. Encapsulation of adjuvants within antiperspirant actives
US4842593A (en) * 1987-10-09 1989-06-27 The Procter & Gamble Company Disposable absorbent articles for incontinent individuals
US5012540A (en) * 1989-12-18 1991-05-07 Hockaday Susan D Disposable sheet protective device
US5019062A (en) * 1988-06-23 1991-05-28 The Procter & Gamble Company Bicomponent material
US5066436A (en) * 1989-01-04 1991-11-19 Gist-Brocades N.V. Process for microencapsulation
US5135747A (en) * 1991-05-17 1992-08-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Deodorant/antiperspirant products with fragrance and encapsulated odor counteractant
US5176903A (en) * 1990-12-13 1993-01-05 Revlon Consumer Products Corporation Antiperspirant/deodorant containing microcapsules
US5194262A (en) * 1990-10-22 1993-03-16 Revlon Consumer Products Corporation Encapsulated antiperspirant salts and deodorant/antiperspirants
WO1994024974A1 (en) * 1993-04-30 1994-11-10 Mcneil-Ppc, Inc. Feminine sanitary napkin
KR20020008379A (ko) * 2001-12-06 2002-01-30 이재식 마이크로캡슐향 나프탈렌 제조 방법
US6369290B1 (en) 2000-02-17 2002-04-09 Tyco Healthcare Retail Services Ag Time release odor control composition for a disposable absorbent article
US20020058917A1 (en) * 2000-09-28 2002-05-16 Takayuki Hisanaka Absorbent article and barrier agent for absorbent article
US20020177828A1 (en) * 1998-12-08 2002-11-28 Batich Christopher D. Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
US6657100B1 (en) * 2000-10-25 2003-12-02 Kimberly-Clark Worldwide, Inc. Toilet training article containing an astringent agent
US6712801B1 (en) * 2000-07-06 2004-03-30 Darryl Richardson Powder dispensing baby diaper
US20040172001A1 (en) * 2000-10-03 2004-09-02 Hanna Tengberg Process for production of an absorpbing sanitary article comprising lactic acid producing bacteria
US20060025731A1 (en) * 2004-08-02 2006-02-02 Cohen Richmond R Reduction of odors in absorbent articles
US7045673B1 (en) 1998-12-08 2006-05-16 Quick-Med Technologies, Inc. Intrinsically bactericidal absorbent dressing and method of fabrication
US7195771B1 (en) 2000-11-21 2007-03-27 Kimberly-Clark Worldwide, Inc. Water-soluble lotions for paper products
US20140257217A1 (en) * 2013-03-05 2014-09-11 Microcapsules Technologies Absorbent article
WO2020261025A1 (en) 2019-06-28 2020-12-30 Ethicon, Inc. Wound closure systems for reducing surgical site infections comprising incision drapes filled with releasable antimicrobial agents

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0147780A3 (en) * 1984-01-03 1987-03-11 Merck & Co. Inc. Drug delivery device
IT1183575B (it) * 1985-05-08 1987-10-22 Eurand Spa Formulazione deodorando ad effetto modulante sulla trfaspirazione
DE3640374A1 (de) * 1986-11-26 1988-06-01 Gerold Tebbe Schweiss - einlagen
GB8719091D0 (en) * 1987-08-12 1987-09-16 Unilever Plc Skin treatment composition
US4992326A (en) * 1987-08-28 1991-02-12 Ncneil-Ppc, Inc. Hydrophilic polymers for incorporating deodorants in absorbent structures
DE59010774D1 (de) * 1990-01-15 1998-01-02 Gerold Tebbe Wirkstoff-imprägniertes tuch
DE19905585A1 (de) * 1999-02-11 2000-08-17 Beiersdorf Ag Verwendung von quaternären Ammoniumverbindungen als Antitranspirantien
DE19936968A1 (de) * 1999-08-05 2001-02-15 Bode Chemie Gmbh & Co Wirkstoffkombination und Fußpflegezubereitungen dieselben enthaltend
DE29914539U1 (de) * 1999-08-19 2000-01-05 Buech Martina Einmal-Babywindel
EP1711058B1 (en) 2004-01-23 2021-09-15 Eden Research Plc Methods of killing nematodes comprising the application of a terpene component
EP1753529B1 (en) 2004-05-20 2013-08-14 Eden Research Plc Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them
KR20140103191A (ko) 2005-11-30 2014-08-25 에덴 리서치 피엘씨 티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법
KR101446580B1 (ko) 2005-11-30 2014-10-02 에덴 리서치 피엘씨 테르펜-함유 조성물 및 이들을 제조하고 사용하는 방법
GB201220940D0 (en) 2012-11-21 2013-01-02 Eden Research Plc Method P
CN115998938A (zh) * 2022-12-29 2023-04-25 福建恒安集团有限公司 一次性卫生用品用功能性胶囊及一次性卫生用品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129921C (xx) * 1958-12-31
FR1521409A (fr) * 1966-01-27 1968-04-19 Ncr Co Matériau en feuille sensible à la pression ou à la chaleur et procédé d'obtention d'un tel matériau
NL134713C (xx) * 1967-07-28

Cited By (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856014A (en) * 1972-10-23 1974-12-24 Jex Co Ltd Sanitary napkin with porous resin powder deodorant
US3875942A (en) * 1972-11-29 1975-04-08 Colgate Palmolive Co Diaper containing powder having properties beneficial to skin
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US4080439A (en) * 1973-02-05 1978-03-21 L'oreal Starch coated antiperspirant derivative of aluminum, process for its preparation and antiperspirant composition containing the same
US4078051A (en) * 1973-02-05 1978-03-07 L'oreal Cross-linked starch coated antiperspirant derivative of aluminum, process for its preparation and antiperspirant composition containing same
US4080438A (en) * 1973-02-05 1978-03-21 L'oreal Starch coated antiperspirant derivative of aluminum, process for its preparation and antiperspirant composition containing the same
US4183911A (en) * 1973-09-18 1980-01-15 Colgate-Palmolive Company Antiperspirant compositions
US3903232A (en) * 1973-10-09 1975-09-02 Grace W R & Co Dental and biomedical foams and method
US3939838A (en) * 1974-08-20 1976-02-24 Unicharm Kabushiki Kaisha Article for treating menstrual fluid
US4369173A (en) * 1974-11-27 1983-01-18 Wickhen Products, Inc. Antiperspirant compositions
US4147766A (en) * 1976-06-09 1979-04-03 Armour Pharmaceutical Company Macrospherical particles of anti-perspirants
US4237591A (en) * 1977-05-23 1980-12-09 Personal Products Company Deodorant mini-pad sanitary napkin
DE2901068A1 (de) * 1978-01-13 1979-07-19 Unilever Nv Desodorierender, poroeser gebrauchsgegenstand zur beruehrung mit menschlicher haut oder haar, verfahren zu seiner herstellung und seine verwendung
US4186743A (en) * 1978-02-28 1980-02-05 Personal Products Company Perfuming self-adhering napkins
US4363322A (en) * 1978-04-13 1982-12-14 Andersson A E Bror Deodorizing and disinfecting liquid-absorbing product and process for production thereof
US4186742A (en) * 1978-06-09 1980-02-05 Donald Enterprises, Inc. Contraceptive-antivenereal disease tampon
US4309997A (en) * 1978-06-09 1982-01-12 Donald Jack W Contraceptive and/or antivenereal disease tampon
WO1980000008A1 (en) * 1978-06-09 1980-01-10 Donald Enterprises Inc Contraceptive-antivenereal disease tampon
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
US4732763A (en) * 1978-10-17 1988-03-22 Stolle Research And Development Corporation Active/passive immunization of the internal female reproductive organs
USRE32713E (en) * 1980-03-17 1988-07-12 Capsule impregnated fabric
US4583980A (en) * 1980-08-16 1986-04-22 Henkel Kommanditgesellschaft Auf Aktien Sanitary hygiene products having odor-preventing properties
US4582717A (en) * 1982-02-06 1986-04-15 Bayer Aktiengesellschaft Process for production of vaginal tampons containing pharmaceutical active compound
US4528125A (en) * 1983-03-03 1985-07-09 The Dow Chemical Company Sustained release compositions
US4818522A (en) * 1987-09-14 1989-04-04 Reheis, Inc. Encapsulation of adjuvants within antiperspirant actives
US4842593A (en) * 1987-10-09 1989-06-27 The Procter & Gamble Company Disposable absorbent articles for incontinent individuals
US5019062A (en) * 1988-06-23 1991-05-28 The Procter & Gamble Company Bicomponent material
US5066436A (en) * 1989-01-04 1991-11-19 Gist-Brocades N.V. Process for microencapsulation
US5012540A (en) * 1989-12-18 1991-05-07 Hockaday Susan D Disposable sheet protective device
US5194262A (en) * 1990-10-22 1993-03-16 Revlon Consumer Products Corporation Encapsulated antiperspirant salts and deodorant/antiperspirants
US5176903A (en) * 1990-12-13 1993-01-05 Revlon Consumer Products Corporation Antiperspirant/deodorant containing microcapsules
US5135747A (en) * 1991-05-17 1992-08-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Deodorant/antiperspirant products with fragrance and encapsulated odor counteractant
WO1994024974A1 (en) * 1993-04-30 1994-11-10 Mcneil-Ppc, Inc. Feminine sanitary napkin
US7709694B2 (en) 1998-12-08 2010-05-04 Quick-Med Technologies, Inc. Materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces
US20020177828A1 (en) * 1998-12-08 2002-11-28 Batich Christopher D. Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation
US7045673B1 (en) 1998-12-08 2006-05-16 Quick-Med Technologies, Inc. Intrinsically bactericidal absorbent dressing and method of fabrication
US6369290B1 (en) 2000-02-17 2002-04-09 Tyco Healthcare Retail Services Ag Time release odor control composition for a disposable absorbent article
EP1267774A1 (en) * 2000-02-17 2003-01-02 Tyco Healthcare Services AG Time release odor control composition and disposable absorbent article utilizing same
EP1267774A4 (en) * 2000-02-17 2007-04-11 Tyco Healthcare Retail Serv Ag US0104844ON RETARDANT ANTI-ODOR AND DISPOSABLE ABSORBENT ARTICLE USING THE SAME
US6712801B1 (en) * 2000-07-06 2004-03-30 Darryl Richardson Powder dispensing baby diaper
US20020058917A1 (en) * 2000-09-28 2002-05-16 Takayuki Hisanaka Absorbent article and barrier agent for absorbent article
US20040172001A1 (en) * 2000-10-03 2004-09-02 Hanna Tengberg Process for production of an absorpbing sanitary article comprising lactic acid producing bacteria
US7960604B2 (en) * 2000-10-03 2011-06-14 Ellen Ab Process for production of an absorbing sanitary article comprising lactic acid producing bacteria
US6911228B2 (en) 2000-10-25 2005-06-28 Kimberly-Clark Worldwide, Inc. Process for manufacturing a toilet training article
US20040015143A1 (en) * 2000-10-25 2004-01-22 Underhill Richard L. Process for manufacturing a toilet training article
US6657100B1 (en) * 2000-10-25 2003-12-02 Kimberly-Clark Worldwide, Inc. Toilet training article containing an astringent agent
US7195771B1 (en) 2000-11-21 2007-03-27 Kimberly-Clark Worldwide, Inc. Water-soluble lotions for paper products
KR20020008379A (ko) * 2001-12-06 2002-01-30 이재식 마이크로캡슐향 나프탈렌 제조 방법
US7834233B2 (en) 2004-08-02 2010-11-16 First Quality Product, Inc. Reduction of odors in absorbent articles
US20060025731A1 (en) * 2004-08-02 2006-02-02 Cohen Richmond R Reduction of odors in absorbent articles
US20140257217A1 (en) * 2013-03-05 2014-09-11 Microcapsules Technologies Absorbent article
US9272070B2 (en) * 2013-03-05 2016-03-01 Microcapsules Technologies Absorbent article
WO2020261025A1 (en) 2019-06-28 2020-12-30 Ethicon, Inc. Wound closure systems for reducing surgical site infections comprising incision drapes filled with releasable antimicrobial agents
US11452641B2 (en) 2019-06-28 2022-09-27 Ethicon, Inc. Wound closure systems for reducing surgical site infections comprising incision drapes filled with releasable antimicrobial agents
US11766364B2 (en) 2019-06-28 2023-09-26 Ethicon, Inc. Wound closure systems for reducing surgical site infections comprising incision drapes filled with releasable antimicrobial agents

Also Published As

Publication number Publication date
FR2033294B1 (xx) 1974-05-03
FR2033294A1 (xx) 1970-12-04
IT1011504B (it) 1977-02-10
CH516309A (fr) 1971-12-15
BE745456A (xx) 1970-08-04
DE2004872A1 (de) 1970-08-06
GB1285244A (en) 1972-08-16
CA952025A (en) 1974-07-30
LU57907A1 (xx) 1970-08-04

Similar Documents

Publication Publication Date Title
US3691271A (en) Sanitary napkin having homogeneously distributed microcapsules filled with delay releasable bactericidal and fungicidal deodorant
JP2574365B2 (ja) デオドラント又は発汗抑制作用を有する芳香づけ組成物、及びデオドラント又は発汗抑制製品
US5783211A (en) Liposome encapsulated active agent dry powder composition
US3729569A (en) Cosmetic composition containing microencapsulated solvents for nail enamel
US5508259A (en) Perfuming composition
US5194262A (en) Encapsulated antiperspirant salts and deodorant/antiperspirants
JP2764143B2 (ja) アジェバントを発汗抑制薬で被包した組成物およびその被包方法
US4906488A (en) Modification of permeant
ES2355477T5 (es) Cápsulas de núcleo-envuelta que contienen un aceite o un sólido ceroso
US2970083A (en) Two phase deodorant-antiperspirant stick
US20040175404A1 (en) Moisture triggered sealed release system
EP2146681B1 (en) Impermeable capsules
JPH0112A (ja) デオドラント又は発汗抑制作用を有する芳香づけ組成物、及びデオドラント又は発汗抑制製品
US2857315A (en) Propylene glycol soap gel stick anti-perspirant
JPH04265149A (ja) 包封する方法及び包封された物質を含有する製品
JP2005533759A (ja) 湿気への応答により芳香バーストを与える芳香成分を含む湿気誘発性放出システム
CA2309334A1 (en) Multiphase stick preparation
CA2008556A1 (en) Perfume composition with deodorizing or antiperspirant action
JP3615534B2 (ja) ローションティッシュペーパー
AU675683B2 (en) Perfuming composition
JPH0881328A (ja) 香料を固定させる植物化合物を含有する化粧料及び／又は皮膚科用組成物
JP3283305B2 (ja) 化粧料
RU2166933C1 (ru) Гигиеническое средство от пота и запаха ног, препаративная форма гигиенического средства и способ их приготовления
JP2004123697A (ja) スキンケアシート
WO2020130982A2 (en) A hygiene product having a controlled fragrance release mechanism